Letters NICE transparency Let cost effectiveness models be open to scrutiny BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39360.379664.BE (Published 11 October 2007) Cite this as: BMJ 2007;335:735 Article Related content Metrics Responses Peer review Related articles Education And Debate Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis Published: 15 February 2003; BMJ 326 doi:10.1136/bmj.326.7385.388 See more Communicating risk to patients in the emergency department BMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437 Biological treatment is approved for severe eosinophilic asthma BMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472 Patient care is at risk from lack of new funds in autumn statement, healthcare leaders warn BMJ November 24, 2016, 355 i6356; DOI: https://doi.org/10.1136/bmj.i6356 Government must be clearer in its claims about NHS funding, says statistics watchdog BMJ November 24, 2016, 355 i6340; DOI: https://doi.org/10.1136/bmj.i6340 US must address addiction as an illness, not as a moral failing, Surgeon General says BMJ November 22, 2016, 355 i6265; DOI: https://doi.org/10.1136/bmj.i6265
